Seres Therapeutics, Inc.MCRBNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank54
5Y CAGR-52.7%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

5Y CAGR
-52.7%/yr
Long-term compound
Percentile
P54
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$789000.00-
2024$0.00-
2023$0.00-
2022$0.00-100.0%
2021$144.93M+336.3%
2020$33.22M-3.7%
2019$34.51M+22.1%
2018$28.27M-11.9%
2017$32.10M+47.5%
2016$21.77M-